Ainos (AIMDW) Competitors $0.06 0.00 (0.00%) (As of 10/4/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsTrends AIMDW vs. ATNFW, LBPSW, AEHAW, ALVOW, ACABW, ACABU, BFRIW, BTMDW, BCTXW, and CELUWShould you be buying Ainos stock or one of its competitors? The main competitors of Ainos include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Alvotech (ALVOW), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), biote (BTMDW), BriaCell Therapeutics (BCTXW), and Celularity (CELUW). These companies are all part of the "pharmaceutical products" industry. Ainos vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics Celularity Ainos (NASDAQ:AIMDW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, media sentiment, community ranking, risk, institutional ownership, earnings, dividends and analyst recommendations. Which has higher valuation & earnings, AIMDW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAinos$65.12KN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Is AIMDW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets AinosN/A N/A N/A 180 Life Sciences N/A N/A N/A Do analysts recommend AIMDW or ATNFW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ainos 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A180 Life Sciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community favor AIMDW or ATNFW? Ainos and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformAinosN/AN/A180 Life SciencesN/AN/A Does the media refer more to AIMDW or ATNFW? In the previous week, 180 Life Sciences had 1 more articles in the media than Ainos. MarketBeat recorded 1 mentions for 180 Life Sciences and 0 mentions for Ainos. 180 Life Sciences' average media sentiment score of 0.98 beat Ainos' score of 0.00 indicating that 180 Life Sciences is being referred to more favorably in the news media. Company Overall Sentiment Ainos Neutral 180 Life Sciences Positive Summary180 Life Sciences beats Ainos on 2 of the 3 factors compared between the two stocks. Ad Weiss RatingsWhat is Nvidia’s New $1 Trillion SuperProject?Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …Find out details on these three critical Nvidia partners immediately. Get Ainos News Delivered to You Automatically Sign up to receive the latest news and ratings for AIMDW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AIMDW vs. The Competition Export to ExcelMetricAinosMedical Devices IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.10B$5.59B$8.44BDividend YieldN/A2.33%4.65%4.07%P/E RatioN/A234.24113.5318.67Price / SalesN/A233.221,142.9272.98Price / CashN/A15.1539.3933.61Price / BookN/A3.904.914.56Net IncomeN/A$69.76M$116.99M$225.27M7 Day PerformanceN/A4.57%3.02%2.49%1 Month PerformanceN/A6.21%16.31%12.52%1 Year PerformanceN/A16.60%24.97%21.33% Ainos Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AIMDWAinosN/A$0.06flatN/AN/A$0.00$65,122.000.0040Gap DownATNFW180 Life SciencesN/A$0.01flatN/A-25.5%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522,000.000.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.05+27.1%N/A-69.1%$0.00N/A0.002Gap DownALVOWAlvotechN/A$2.98+5.7%N/A+53.6%$0.00$306.77M0.004Gap UpACABWAtlantic Coastal Acquisition Corp. IIN/A$0.05flatN/AN/A$0.00N/A0.004Positive NewsACABUAtlantic Coastal Acquisition Corp. IIN/A$11.50flatN/AN/A$0.00N/A0.004Positive NewsGap UpBFRIWBiofronteraN/A$0.02-33.3%N/A-45.1%$0.00$35.24M0.0070Positive NewsGap DownHigh Trading VolumeBTMDWbioteN/A$0.60+14.9%N/AN/A$0.00$187.23M0.00N/AGap UpBCTXWBriaCell TherapeuticsN/A$0.31-13.9%N/A-85.7%$0.00N/A0.008Gap DownCELUWCelularityN/A$0.01flatN/A-42.6%$0.00$22.77M0.00220Gap UpHigh Trading Volume Related Companies and Tools Related Companies: 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Alvotech Competitors Atlantic Coastal Acquisition Corp. II Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Celularity Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AIMDW) was last updated on 10/5/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredThe Bible Says it Clear As DayIt came to me clear-as-day thanks to the Bible… in the Parable of Talents, in the book of Matthew… This pa...Prosperity Research | SponsoredKamala’s Dirty Election Move… RevealedAccording to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppe...Paradigm Press | Sponsored“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed ...InvestorPlace | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | SponsoredAI Expert Reveals New PickEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredNext opportunity for crypto millionsAll the Pieces Falling into Place for Crypto… Unlock the Potential of the 2024 Crypto Bull Run!Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ainos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ainos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.